Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NurrOn Pharmaceuticals, INC Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of NurrOn Pharmaceuticals, INC, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Nature Cell Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Nature Cell, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
7 min read
Montara Therapeutics, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Montara Therapeutics, Inc, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Aristo Pharma GmbH Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Aristo Pharma GmbH, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Arisan Therapeutics, Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Arisan Therapeutics, Inc, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Aether Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Aether Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Allosite Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Allosite Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
TopAlliance Biosciences, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of TopAlliance Biosciences, Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Tianli Biotech Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Tianli Biotech, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Architect Therapeutics, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Architect Therapeutics, Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Argenica Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Argenica Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Aegle Therapeutics Corp Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Aegle Therapeutics Corp, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.